THE INFLUENCE OF CLINICAL STUDY INCLUSION CRITERIA ON BASELINE CHARACTERISTICS AND DISEASE PROGRESSION IN AMYOTROPHIC LATERAL SCLEROSIS

被引：0
|
作者：
Katz, Jonathan [1 ]
Perdrizet, Johnna [2 ]
Apple, Stephen [2 ]
Zhang, Jeffrey [3 ]
Lu, Peter [3 ]
Agnese, Wendy [2 ]
机构：
[1] Calif Pacific Med Ctr, Dept Neurol, Forbes Norris MDA ALS Ctr, San Francisco, CA USA
[2] Mitsubishi Tanabe Pharma Amer Inc, Jersey City, NJ USA
[3] Princeton Pharmatech, Princeton, NJ USA
来源：
MUSCLE & NERVE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
8
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] ANTECEDENT EVENTS IN AMYOTROPHIC-LATERAL-SCLEROSIS - DO THEY INFLUENCE CLINICAL ONSET AND PROGRESSION
    PROVINCIALI, L
    GIOVAGNOLI, AR
    [J]. NEUROEPIDEMIOLOGY, 1990, 9 (05) : 255 - 262
  • [22] Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone
    Fidler, Jonathan A.
    Treleaven, Christopher M.
    Frakes, Ashley
    Tamsett, Thomas J.
    McCrate, Mary
    Cheng, Seng H.
    Shihabuddin, Lamya S.
    Kaspar, Brian K.
    Dodge, James C.
    [J]. FASEB JOURNAL, 2011, 25 (12): : 4369 - 4377
  • [23] Accuracy of clinical and electrophysiological criteria for diagnosing amyotrophic lateral sclerosis
    Finsterer, Josef
    [J]. CLINICAL NEUROPHYSIOLOGY, 2016, 127 (07) : 2682 - 2683
  • [24] Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression
    Blasco, H.
    Nadal-Desbarats, L.
    Pradat, P. -F.
    Gordon, P. H.
    Hounoum, B. Madji
    Patin, F.
    Veyrat-Durebex, C.
    Mavel, S.
    Beltran, S.
    Emond, P.
    Andres, C. R.
    Corcia, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (02) : 346 - 353
  • [25] Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
    van Eijk, Ruben P. A.
    Westeneng, Henk-Jan
    Nikolakopoulos, Stavros
    Verhagen, Iris E.
    van Es, Michael A.
    Eijkemans, Marinus J. C.
    van den Berg, Leonard H.
    [J]. NEUROLOGY, 2019, 92 (05) : E451 - E460
  • [26] Identification of novel biomarkers of amyotrophic lateral sclerosis clinical progression
    Pasinetti, Giulio M.
    Lange, Dale
    Cudkowicz, Merit
    Brown, Robert
    Peskind, Elaine
    Ho, Lap
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S80 - S80
  • [27] BULBAR AMYOTROPHIC LATERAL SCLEROSIS - PATTERNS OF PROGRESSION AND CLINICAL MANAGEMENT
    HILLEL, AD
    MILLER, R
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1989, 11 (01): : 51 - 59
  • [28] Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
    Koji Yamanaka
    Seung Joo Chun
    Severine Boillee
    Noriko Fujimori-Tonou
    Hirofumi Yamashita
    David H Gutmann
    Ryosuke Takahashi
    Hidemi Misawa
    Don W Cleveland
    [J]. Nature Neuroscience, 2008, 11 : 251 - 253
  • [29] Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression
    Femiano, Cinzia
    Bruno, Antonio
    Gilio, Luana
    Buttari, Fabio
    Dolcetti, Ettore
    Galifi, Giovanni
    Azzolini, Federica
    Borrelli, Angela
    Furlan, Roberto
    Finardi, Annamaria
    Musella, Alessandra
    Mandolesi, Georgia
    Storto, Marianna
    Centonze, Diego
    Stampanoni Bassi, Mario
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
    Yamanaka, Koji
    Chun, Seung Joo
    Boillee, Severine
    Fujimori-Tonou, Noriko
    Yamashita, Hirofumi
    Gutmann, David H.
    Takahashi, Ryosuke
    Misawa, Hidemi
    Cleveland, Don W.
    [J]. NATURE NEUROSCIENCE, 2008, 11 (03) : 251 - 253
12345